2018
P038 Donor specific anti-a titer for abo incompatible (ABOi) living kidney transplantation
Miller M, Bow L. P038 Donor specific anti-a titer for abo incompatible (ABOi) living kidney transplantation. Human Immunology 2018, 79: 88. DOI: 10.1016/j.humimm.2018.07.096.Peer-Reviewed Original ResearchABO-incompatible donorsKidney transplantationLiving donorsRed cellsTiter resultsA2 red cellsBlood group A antigensReactive IgG antibodiesTime of transplantGroup A antigensKidney donor programsBlood group BABOi transplantsRejection episodesRecipient serumAbsolute contraindicationDonor transplantsIgG titersDeceased donorsDonor optionsIgG antibodiesGroup BA antigenIncompatible donorsA2 cells
2015
Case study: Use of A2 and donor red blood cells for anti ABO a titer
Miller M, Bow L. Case study: Use of A2 and donor red blood cells for anti ABO a titer. Human Immunology 2015, 76: 97. DOI: 10.1016/j.humimm.2015.07.141.Peer-Reviewed Original ResearchDonor RBCsIgG titersABO incompatibilityTransplant programsBlood group O recipientsBlood group A antigensWeak antigen expressionABO-incompatible transplantsGroup O recipientsBlood group OYear old maleGroup A antigensBlood group AA1 RBCsABOi transplantsIncompatible transplantsKidney transplantationRecipient serumAbsolute contraindicationKidney transplantRed blood cellsAntibody titersAntigen subtypesO recipientsIgG antibodies
2012
45-P WHEN A DSA IS NOT A DSA: POSITIVE VIRTUAL CROSSMATCHES RESULTING IN ACTUAL NEGATIVE CROSSMATCHES
Rewinski M, Ortiz J, Bared K, Alberghini T, Bow L. 45-P WHEN A DSA IS NOT A DSA: POSITIVE VIRTUAL CROSSMATCHES RESULTING IN ACTUAL NEGATIVE CROSSMATCHES. Human Immunology 2012, 73: 78. DOI: 10.1016/j.humimm.2012.07.171.Peer-Reviewed Original ResearchDonor-specific antibodiesPositive virtual crossmatchVirtual crossmatchMFI levelsUnacceptable antigensClass ILuminex single antigenNegative flow crossmatchKidney transplant recipientsSuccessful kidney transplantationDonor cellsKidney waiting listPotential kidney recipientsHLA class IKidney recipientsTransplant recipientsKidney transplantationFlow crossmatchAntibody testingNegative crossmatchPatient seraAntibody assaysLuminex assaysWaiting listCrossmatch39-P INCREASING MFI CUTOFFS FOR UNACCEPTABLE ANTIGENS INCREASES ACCESS TO ACTUAL DECEASED DONOR CROSSMATCHES FOR THE SENSITIZED RECIPIENT
Miller M, Alberghini T, Rewinski M, Bow L. 39-P INCREASING MFI CUTOFFS FOR UNACCEPTABLE ANTIGENS INCREASES ACCESS TO ACTUAL DECEASED DONOR CROSSMATCHES FOR THE SENSITIZED RECIPIENT. Human Immunology 2012, 73: 74. DOI: 10.1016/j.humimm.2012.07.165.Peer-Reviewed Original ResearchUnacceptable antigensB cellsB-cell crossmatchPositive flow crossmatchLow-level antibodyHLA class IResultsFifty-sixSensitized recipientsKidney transplantationPositive crossmatchFlow crossmatchVirtual crossmatchDonor workupDP antibodiesNegative control seraLuminex assaysCrossmatchHigh MFI valuesControl seraFlow cytometryMultiple antibodiesClass IRecipientsAntibodiesMatch runs
2001
Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization
Benedetto B, Lipkowitz G, Madden R, Kurbanov A, Hull D, Miller M, Bow L. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. Journal Of Vascular Surgery 2001, 34: 139-142. PMID: 11436087, DOI: 10.1067/mva.2001.114206.Peer-Reviewed Original ResearchConceptsVein allograftsHemodialysis accessPRA valuesControl cohortPRA assaysWaiting listKidney transplantation waiting listPanel-reactive antibodies valuesPotential kidney transplant recipientsUniversity-affiliated medical centerMajor histocompatibility complex IKidney transplant recipientsHistory of transfusionTransplant waiting listTransplantation waiting listMean PRANonimmunosuppressed individualsHemodialysis populationKidney transplantationPrior transplantationTransplant recipientsConsecutive patientsProsthetic graftsAntibody valuesKidney failure
1996
Organ transplantation at the Hartford Transplant Center.
Schweizer R, Bartus S, Hull D, Perdrizet G, Swanson M, Low H, Gallagher R, Dougherty J, Rosson R, Hyams J, D'Avella J, Rasoulpour M, Sullivan P, Bow L. Organ transplantation at the Hartford Transplant Center. Connecticut Medicine 1996, 60: 387-93. PMID: 8758656.Peer-Reviewed Original ResearchConceptsTransplant centersActuarial graft survivalRecipients of kidneysMost transplant centersTwo-year survivalHealth care communityTriple immunosuppressionGraft survivalKidney transplantationLiver transplantRelated donorsCadaveric kidneysHigh success rateDonor organsOrgan transplantationOrgan transplantsPancreas patientsKidneySuccess rateSurvivalTransplantationTransplantNational averageHeartImmunosuppression
1988
Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
Schweizer R, Bow L, Roper L, Hull D, Bartus S. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression. Clinical Transplants 1988, 147-58. PMID: 3154467.Peer-Reviewed Original ResearchConceptsLiving-related donor kidney transplantsDonor kidney transplantsCadaver kidney transplant recipientsKidney transplant recipientsGraft survivalKidney transplantOKT3 therapyTriple immunosuppressionTransplant recipientsHartford HospitalControl groupPretransplant blood transfusionsPrevious control groupSteroid-resistant rejectionUse of OKT3Year graft survivalMean serum creatinineEuro-Collins solutionAddition of CsAKidney transplantationRenal transplantationCMV infectionSerum creatinineBlood transfusionDR matching
1980
Successful kidney transplantation despite T lymphocyte cytotoxicity: Role of donor specific blood transfusion
Schweizer R, Bow L, Hosey D, Bartus S. Successful kidney transplantation despite T lymphocyte cytotoxicity: Role of donor specific blood transfusion. Human Immunology 1980, 1: 283-284. DOI: 10.1016/0198-8859(80)90078-6.Peer-Reviewed Original Research